
Overcoming cold-chain logistical challenges when delivering life-saving MS therapies
With the MS Trust estimating that more than 2.9 million people worldwide have multiple sclerosis (MS), new therapies are urgently needed to support those with the condition. [i] Yet significant challenges arise when exporting such therapies around the …